Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001897612-25-000181·HAEMONETICS CORP
Schedule 13G ownership disclosure
Haemonetics Corp
COMMON STOCK · CUSIP: 405024100
Event date: 2025-03-31
- Filing-level shares
- 2,195,569
- Percent of class
- 4.4%
- T. Rowe Price Investment Management, Inc.
Shares: 2,195,569 · Class: 4.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-25-000181
- Form type
- SCHEDULE 13G/A
- Filer
- HAEMONETICS CORP
- CIK
- CIK 313143
- Filed
- May 14, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership